Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

The use of chemotherapy in premenopausal cancer patients may lead to chemotherapy-induced premature ovarian failure. Pharmacological temporary ovarian suppression obtained with the gonadotropin-releasing hormone agonist (GnRHa) administered concomitantly with chemotherapy has been investigated as a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Med Insights Reprod Health
Autors principals: Poggio, Francesca, Lambertini, Matteo, Bighin, Claudia, Conte, Benedetta, Blondeaux, Eva, D’Alonzo, Alessia, Dellepiane, Chiara, Buzzatti, Giulia, Molinelli, Chiara, Boccardo, Francesco, Del Mastro, Lucia
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Fertility Preservation: Present Practice and Future Endeavors
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6669835/
https://ncbi.nlm.nih.gov/pubmed/31391786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179558119864584
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars